Back to results
US 10,472,418 B2Granted
Composition for preventing or treating lung cancer comprising antibody against CD66C and chemotherapeutic agent
AssigneeDinona Inc.
InventorsKwon Pyo Hong, Mi Hyang Shin, Sangsoon Yoon, Gil Yong Ji, Yoo Ri Moon
Life of this patent
Estimating the term…
Abstract
A use of prevention or treatment of lung cancer including an antibody specifically recognizing CD66c in lung cancer or its antigen-binding fragment and a chemotherapeutic agent is provided.
Claims6
A method of treating a lung cancer, comprising administering an anti-CD66c (Cluster of Differentiation 66c) antibody being specific to a lung adenocarcinoma or an antigen-binding fragment thereof, and a chemotherapeutic agent as effective agent, to a subject in need,
- wherein the anti-CD66c antibody is an antibody produced by hybridoma cell deposited as an accession number of KCLRF-BP-00230, and
- wherein the chemotherapeutic agent is paclitaxel.
Dependencies are inferred from the claim text.